Top compounds associated with response to FN3K


Feature Type Standardized
Nominal ANOVA
mRNA Sunitinib CTRPv2 pan-cancer AAC 0.035 0.3
mRNA AZD8055 GDSC1000 pan-cancer AAC -0.033 0.3
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.033 0.3
mRNA EHT 1864 GDSC1000 pan-cancer AAC -0.034 0.3
mRNA PL-DI CTRPv2 pan-cancer AAC 0.032 0.3
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.039 0.3
mRNA neopeltolide CTRPv2 pan-cancer AAC 0.075 0.3
mRNA Tipifarnib GDSC1000 pan-cancer AAC 0.035 0.3
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.033 0.3
mRNA IOX2 GDSC1000 pan-cancer AAC -0.033 0.3
Download CSV